| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-551 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04 |
| filingDate |
2005-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2008-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2008507484-A |
| titleOfInvention |
Process for producing 3- (4-piperidinyl) -2,3,4,5-tetrahydro-1,3-benzodiazepin-2 (1H) -one |
| abstract |
The present invention relates to a process for the preparation of the compound 3- (4-piperidinyl) -2,3,4,5-tetrahydro-1,3-benzodiazepin-2 (1H) -one of the formula (I) Can be found as a structural component in CGRP antagonists suitable primarily for oral treatment of migraine. [Chemical 1] |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009521420-A |
| priorityDate |
2004-07-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |